Aleteia logoAleteia logo
Friday 24 September |
The Blessed Virgin Mary—Our Lady of Walsingham
home iconNews
line break icon

New gene therapy for leukemia: FDA panel advises approval


Alexander Raths - Shutterstock

J-P Mauro - published on 07/13/17 - updated on 07/13/17

The one time treatment boasts higher success rate than chemotherapy

An FDA panel of cancer experts endorsed a new treatment for leukemia. The group met Wednesday and voted unanimously to recommend the treatment’s approval. The FDA is not required to adhere to their suggestion, but if they do, this could be the first gene therapy to be possible in the US.

Fox News reports, the treatment is meant for children and young adults, ages 3-25, who are afflicted with the advanced stages of Leukemia:

CAR-T therapy starts with filtering key immune cells called T cells from a patient’s blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancers. Millions of copies of the new T cells are grown in the lab and then injected into the patient’s bloodstream where they can seek out and destroy cancer cells. Doctors call it a “living drug” — permanently altered cells that continue to multiply in the body into an army to fight the disease.

The panel heard from the fathers of two patients whose lives have already been saved by the experimental gene therapy. Of the 52 patients analyzed, 83% were in complete remission. The side affects are severe, but nearly all recovered.

While the treatment is very expensive, as a one time procedure it may have a net effect of lowering medical costs, and is expected to be more effective than chemotherapy.

Support Aleteia!

If you’re reading this article, it’s thanks to the generosity of people like you, who have made Aleteia possible.

Here are some numbers:

  • 20 million users around the world read every month
  • Aleteia is published every day in seven languages: English, French, Italian, Spanish, Portuguese, Polish, and Slovenian
  • Each month, readers view more than 50 million pages
  • Nearly 4 million people follow Aleteia on social media
  • Each month, we publish 2,450 articles and around 40 videos
  • We have 60 full time staff and approximately 400 collaborators (writers, translators, photographers, etc.)

As you can imagine, these numbers represent a lot of work. We need you.

Support Aleteia with as little as $1. It only takes a minute. Thank you!

Daily prayer
And today we celebrate...

Top 10
Cecilia Pigg
7 Ways the saints can help you sleep better at night
Philip Kosloski
An alternative Hail Mary to Our Lady of Sorrows
Our Lady of La Salette
Philip Kosloski
How Our Lady of La Salette can give us hope in darkness
Philip Kosloski
Pray this Psalm when you successfully recover from an illness
Philip Kosloski
Why J.R.R. Tolkien loved to attend daily Mass
Domitille Farret d'Astiès
Attacked with acid as a baby, Anmol Rodriguez overcomes and inspi...
Aid to the Church in Need
What happens when a million children pray the Rosary?
See More
Get Aleteia delivered to your inbox. Subscribe here.